Video

Educated Patient® Leukemia Summit: July 31, 2021

View the full CURE Educated Patient Leukemia Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
Related Content
PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer: © stock.adobe.com.
August 23rd 2025

Key Immune Cells Linked to Better Kidney Cancer Outcomes

Ashley Chan
cancer horizons logo: a white microphone on a navy blue background
August 23rd 2025

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe subtypes: © stock.adobe.com.
August 23rd 2025

Clinical Trial Confirms Keytruda and Lenvima Benefit in Kidney Cancer

Russ Conroy
cancer horizons image for podcast
August 23rd 2025

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
Image of kidney.
August 23rd 2025

Welireg Improves Quality-Adjusted Survival Time in Advanced RCC

Russ Conroy
Researchers are exploring the use of CAR T-cell therapy in clear cell renal cell carcinoma, a type of kidney cancer: © stock.adobe.com.
August 23rd 2025

Dual-Targeting CAR T Therapy Shows Potential in Advanced Kidney Cancer

Ashley Chan